Making Markets for Vaccines
21,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
11 °P sammeln
  • Broschiertes Buch

Making a commitment in advance to buy vaccines if and when they are developed would create incentives for industry to increase investment in research and development. New commercial investment would complement funding of research and development by public and charitable bodies, accelerating the development of vital new vaccines for the developing world. This report presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. By creating arrangements that devote the same scientific effort to diseases of the poor as we…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Making a commitment in advance to buy vaccines if and when they are developed would create incentives for industry to increase investment in research and development. New commercial investment would complement funding of research and development by public and charitable bodies, accelerating the development of vital new vaccines for the developing world. This report presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. By creating arrangements that devote the same scientific effort to diseases of the poor as we put into diseases of the rich, we can make a lasting contribution to the defeat of poverty.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Ruth Levine, senior fellow and Director of Programs at the Center for Global Development, currently leads the Center's Global Health Policy Research Network, USA. Michael Kremer is a professor in the Department of Economics at Harvard University, and senior fellow at the Brookings Institution, USA. Alice Albright is the Chief Executive Officer for the Global Partnership for Education, USA.